Join
Live feed
·
INSIDERFilingvia Quantisnow
Cara Therapeutics Inc. logo

Director Wirk Shaheen was granted 4,191 shares and acquired 439,194 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CARA· Cara Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CARA (Cara Therapeutics Inc.) and more on Quantisnow.